Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses

dc.contributor.authorSastry, Lakshmi
dc.contributor.authorXu, Yi
dc.contributor.authorJohnson, Terry
dc.contributor.authorDesai, Kunal
dc.contributor.authorRissing, David
dc.contributor.authorMarsh, Jonathan
dc.contributor.authorCornetta, Kenneth
dc.contributor.departmentMicrobiology and Immunology, School of Medicineen_US
dc.date.accessioned2022-12-08T22:20:43Z
dc.date.available2022-12-08T22:20:43Z
dc.date.issued2003-11-01
dc.description.abstractA principal concern regarding the safety of HIV-1-based vectors is replication-competent lentivirus (RCL). We have developed two PCR assays for detecting RCL; the first detects recombination between gag regions in the transfer vector and the packaging construct (sensitivity of detection ∼10–100 copies of target sequence). The second assay uses real-time PCR to detect vesicular stomatitis virus glycoprotein (VSVG) envelope DNA (sensitivity ∼5–50 VSVG sequences). In an attempt to amplify any RCL, test vectors were used to transduce C8166 and 293 cells, which were then screened weekly for 3 weeks. Psi–gag recombinants were routinely detected (20 of 21 analyses) in four transductions using the RRL-CMV-GFP vector. In contrast, VSVG sequences were detected only once in 21 analyses. Interestingly, p24 levels (as measured by ELISA) were occasionally detectable after 3 weeks of culture. To determine if a true RCL was present, 21-day cell-free medium was used to transduce naïve cells. No evidence of psi–gag or VSVG transfer was detected, indicating that the recombination events were insufficient to reconstitute a true RCL. These findings have important implications for the design and safety of HIV-1-based vectors intended for clinical applications.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationSastry, L., Xu, Y., Johnson, T., Desai, K., Rissing, D., Marsh, J., & Cornetta, K. (2003). Certification assays for HIV-1-based vectors: Frequent passage of gag sequences without evidence of replication-competent viruses. Molecular Therapy, 8(5), 830–839. https://doi.org/10.1016/j.ymthe.2003.08.003en_US
dc.identifier.issn1525-0016en_US
dc.identifier.urihttps://hdl.handle.net/1805/30689
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.ymthe.2003.08.003en_US
dc.relation.journalMolecular Therapyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePublisheren_US
dc.subjectlentivirusen_US
dc.subjectp24 ELISAen_US
dc.subjectPCRen_US
dc.titleCertification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent virusesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S1525001603002703-main.pdf
Size:
310.1 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: